Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microglia

关键词:heat shock factor 1 lipopolysaccharide 

摘要:Aim Inducible nitric oxide synthase (iNOS) makes a great contribution to host defense and inflamma-tion. In many settings, lipopolysaccharide (LPS) induces iNOS expression through activation of the inhibitor of KB- α (IKB-α) -nuclear factor-KB (NF-KB) cascade, whereas interferon-γ (IFN-γ) acts through Janus kinase ( JAK)- signal transducer and activator of transcription 1 ( STAT1 ) signals. Heat shock factor 1 ( HSF1 ), a major regulator of heat shock protein transcription, has been shown to regulate the production of pro-inflammatory cytokines such as tumor necrosis factor-α(TNF-α) and interleukin-6 (IL-6). But it remains obscure whether and how HSF1 affects iNOS induction. Methods Western blot was used to measure the protein expression. The mRNA level was meas- ured by real time-PCR. Silence of HSF1 was achieved by small interfering RNA. Nitric oxide (NO) content and NF-KB binding activity were assayed by commercial kits. Chromatin immunoprecipitation (CHIP) was used to measure the binding activity of NF-KB and STAT1 to iNOS promoters. Results HSF1 inhibition or knockdown pre- vented the LPS- and/or IFN-γ-stimulated iNOS protein expression in cultured microglia. HSF1 inhibition blocked iNOS mRNA transcription. These inhibitory effects of HSF1 inhibition on iNOS expression were confirmed in brain tissues from endotoxemic mice. Further analysis showed that HSF1 inhibition had no effect on IKB-α degradation and NF-KB or STAT1 phosphorylation in LPS/IFN-γ-stimulated cells. The nuclear transport of active NF-KB or STAT1 was also not affected by HSF1 inhibition. But HSF1 inhibition reduced the binding of NF-KB and STAT1 to their DNA elements. In addition, HSF1 inhibition reduced NF-KB and STAT1 bindings to iNOS promoter inside the LPS/IFN-γ-stimulated cells. Conclusions This preventing effect of HSF1 inhibition on iNOS mRNA transcription presents the necessary role of HSF1 in iNOS induction.

中国药理学通报杂志要求:

{1}来稿应写清作者姓名、单位、邮编、准确通信地址及联系电话,并附所有作者简介。

{2}本刊实行匿名评审。处理稿件以3个月为限,逾期如未接到录用通知,可自行处理。稿件概不退还,烦请自留底稿。来稿请勿一稿多投,如发现一稿多投,5年以内不再受理投稿。

{3}文内标题层次一般不超过3级,一律用1、1.1、1.2、1.1.1、1.1.2等标识,均顶格写。

{4}论文所引文献必须是作者阅读过的、最主要的、公开出版的文献;未公开发表的、且很有必要引用的,请采用脚注方式标明。

{5}摘要应准确概括全文中心议题,字数为200~300字。所列关键词为3~8个词组,且不应和文题中心词雷同。

注:因版权方要求,不能公开全文,如需全文,请咨询杂志社

中国药理学通报

北大期刊
1-3个月下单

关注 11人评论|0人关注
服务与支付